Raaj Medisafe India Limited (BOM:524502)
India
· Delayed Price · Currency is INR 88.90
0.00 (0.00%)
At close: Mar 5, 2026
Raaj Medisafe India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 793.39 | 624.2 | 432.49 | 386.23 | 346.94 | 318.05 | Upgrade
|
| Revenue | 793.39 | 624.2 | 432.49 | 386.23 | 346.94 | 318.05 | Upgrade
|
| Revenue Growth (YoY) | 60.68% | 44.33% | 11.98% | 11.32% | 9.08% | 45.92% | Upgrade
|
| Cost of Revenue | 537.5 | 442.96 | 295.26 | 270.56 | 266.87 | 252.75 | Upgrade
|
| Gross Profit | 255.88 | 181.25 | 137.23 | 115.67 | 80.07 | 65.3 | Upgrade
|
| Selling, General & Admin | 50.13 | 40.27 | 33.2 | 27.72 | 29.06 | 24.54 | Upgrade
|
| Other Operating Expenses | 84.1 | 54.66 | 37.67 | 31.83 | 0.1 | 0.04 | Upgrade
|
| Operating Expenses | 152.77 | 109.41 | 79.25 | 67.07 | 36.4 | 31.69 | Upgrade
|
| Operating Income | 103.11 | 71.84 | 57.98 | 48.6 | 43.67 | 33.61 | Upgrade
|
| Interest Expense | -34.51 | -20.18 | -14.56 | -10.59 | -6.62 | -7.31 | Upgrade
|
| Interest & Investment Income | 1.75 | 1.75 | 0.5 | 0.11 | 0.21 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.01 | 0.06 | 0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.06 | -0.87 | -1.04 | -0.46 | -0.51 | -0.08 | Upgrade
|
| EBT Excluding Unusual Items | 71.41 | 52.55 | 42.89 | 37.72 | 36.75 | 26.31 | Upgrade
|
| Other Unusual Items | - | - | - | -0.01 | 0.53 | -0.12 | Upgrade
|
| Pretax Income | 71.41 | 52.55 | 42.89 | 37.72 | 37.27 | 26.19 | Upgrade
|
| Income Tax Expense | -9.55 | -8.76 | 9.6 | 4.42 | 7.15 | 3.19 | Upgrade
|
| Net Income | 80.97 | 61.31 | 33.29 | 33.3 | 30.13 | 22.99 | Upgrade
|
| Net Income to Common | 80.97 | 61.31 | 33.29 | 33.3 | 30.13 | 22.99 | Upgrade
|
| Net Income Growth | 141.71% | 84.20% | -0.04% | 10.52% | 31.03% | - | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Change (YoY) | 3.48% | 20.87% | - | 2.06% | -3.82% | 15.36% | Upgrade
|
| EPS (Basic) | 6.18 | 4.65 | 3.05 | 3.05 | 2.82 | 2.07 | Upgrade
|
| EPS (Diluted) | 6.13 | 4.60 | 3.05 | 3.05 | 2.82 | 2.07 | Upgrade
|
| EPS Growth | 131.59% | 50.69% | -0.04% | 8.29% | 36.23% | - | Upgrade
|
| Free Cash Flow | - | -147.96 | -73.64 | -15.52 | 12.35 | -16.6 | Upgrade
|
| Free Cash Flow Per Share | - | -11.23 | -6.75 | -1.42 | 1.16 | -1.50 | Upgrade
|
| Gross Margin | 32.25% | 29.04% | 31.73% | 29.95% | 23.08% | 20.53% | Upgrade
|
| Operating Margin | 13.00% | 11.51% | 13.41% | 12.58% | 12.59% | 10.57% | Upgrade
|
| Profit Margin | 10.21% | 9.82% | 7.70% | 8.62% | 8.68% | 7.23% | Upgrade
|
| Free Cash Flow Margin | - | -23.71% | -17.03% | -4.02% | 3.56% | -5.22% | Upgrade
|
| EBITDA | 122.18 | 86.32 | 66.35 | 56.12 | 50.91 | 40.72 | Upgrade
|
| EBITDA Margin | 15.40% | 13.83% | 15.34% | 14.53% | 14.67% | 12.80% | Upgrade
|
| D&A For EBITDA | 19.07 | 14.48 | 8.37 | 7.52 | 7.24 | 7.11 | Upgrade
|
| EBIT | 103.11 | 71.84 | 57.98 | 48.6 | 43.67 | 33.61 | Upgrade
|
| EBIT Margin | 13.00% | 11.51% | 13.41% | 12.58% | 12.59% | 10.57% | Upgrade
|
| Effective Tax Rate | - | - | 22.39% | 11.72% | 19.17% | 12.19% | Upgrade
|
| Revenue as Reported | 797.3 | 626.19 | 433.09 | 386.45 | 347.2 | 318.25 | Upgrade
|
| Advertising Expenses | - | 0.32 | 0.15 | 0.18 | 0.12 | 0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.